Drug & Supplement Interactions

Yohimbe + Osimertinib Mesylate

Brand name of Osimertinib Mesylate

  • Tagrisso

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

Theoretically, CYP3A4 inhibitors might increase the levels and adverse effects of yohimbine, a constituent of yohimbe bark. Of the 2 interaction records for this pair, the most serious is rated moderate.

This also applies to Tagrisso, a brand name of osimertinib mesylate.

Read the Full Interaction Report Dr. Brian Staiger, PharmD, Explains What This Interaction Means for You Why it happens, what you might notice and what to do, in plain words.1-minute read
Moderate
Possible
2
D

Ask a Question About This Combination

Ask in your own words about taking Yohimbe with Osimertinib Mesylate. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Yohimbe and Osimertinib Mesylate Interaction

2 interaction records apply to these two. Each one is explained separately below.

Why Are There 2 Interaction Records?

We file Yohimbe’s interactions under single medicines and under categories of medicines that share an effect. Osimertinib Mesylate is named in, or belongs to, 2 of them, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 2

Yohimbe With Cytochrome P450 3A4 (CYP3A4) Inhibitors

Why this applies to Osimertinib Mesylate

  1. The SupplementYohimbe
  2. Interacts With the CategoryCytochrome P450 3A4 (CYP3A4) Inhibitors
  3. Which IncludesOsimertinib Mesylate

We sort drugs into categories. Osimertinib Mesylate is in our Cytochrome P450 3A4 (CYP3A4) Inhibitors category, and Yohimbe interacts with every drug in it, so this interaction applies to Osimertinib Mesylate.

Interaction Details Explained

Theoretically, CYP3A4 inhibitors might increase the levels and adverse effects of yohimbine, a constituent of yohimbe bark.
In vitro and clinical research shows that the yohimbe bark constituent, yohimbine, is metabolized by CYP3A4 enzymes. Theoretically, drugs that inhibit CYP3A4 might increase the levels and adverse effects of yohimbine.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on what is expected from how the two work, not yet studied.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Yohimbe + Cytochrome P450 3A4 (CYP3A4) Inhibitors Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the key thing to understand: in this pairing, it's the yohimbe that may build up, not your Tagrisso. Yohimbine (the active part of yohimbe) is broken down by an enzyme called CYP3A4, and osimertinib can mildly slow that same enzyme. So your cancer treatment itself shouldn't change, but the yohimbine could hang around longer and hit harder.

That matters because yohimbe already tends to raise blood pressure and speed up your heart rate, and can cause anxiety, jitteriness, and headaches. More of it in your system means more of those effects. To be fair, this concern is theoretical, based on how the two are processed rather than real-world reports. Still, since you're being treated for lung cancer, please run any yohimbe use past your oncologist or pharmacist first.

Still have a question about this interaction?

Contact Dr. Brian directly

References 2 sources behind this record

  1. Le Corre P, Parmer RJ, Kailasam MT, et al. Human sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolism. Clin Pharmacol Ther. 2004;76(2):139-53.
  2. Bharucha AE, Skaar T, Andrews CN, et al Relationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjects. Neurogastroenterol Motil. 2008;20(8):891-9. PubMed
Minor Interaction 2 of 2

Yohimbe With Cytochrome P450 3A4 (CYP3A4) Substrates

Osimertinib Mesylate is also in our Cytochrome P450 3A4 (CYP3A4) Substrates category.

Interaction Details Explained

Theoretically, yohimbe might decrease the levels and clinical effects of CYP3A4 substrates.
In vitro research shows that yohimbe extract induces CYP3A4 enzymes.
Severity
MinorLimited concern, but worth mentioning to your pharmacist.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Yohimbe + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the basic idea with these two together. Osimertinib (Tagrisso) is your active cancer medicine, and your liver clears it using an enzyme called CYP3A4. Lab studies suggest yohimbe may speed that enzyme up. In theory, a faster enzyme could clear osimertinib a little quicker, which might lower its levels and, at least on paper, make it work less well against your lung cancer.

I want to be honest about the evidence here: this comes only from test-tube research, not from people, so it's rated minor and theoretical. Still, osimertinib is a serious medicine where you don't want anything chipping away at how well it works. Yohimbe also carries its own risks, like high blood pressure and a racing heart. Please check with your oncologist or pharmacist before adding it.

Still have a question about this interaction?

Contact Dr. Brian directly

References 1 source behind this record

  1. Haron MH, Dale O, Martin K, et al. Evaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2. J Diet Suppl 2022. PubMed
Know someone taking this combination? Share

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Yohimbe and Osimertinib Mesylate

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Yohimbe or Osimertinib Mesylate, not necessarily both.

  1. The pharmacist says

    Lovin' Libido is unlikely to cause a serious interaction with Effexor XR (venlafaxine), though the combination has not been specifically studied.

    Answered by Dr. Brian Staiger, PharmD · October 2026
  2. The pharmacist says

    Red yeast rice can interact with Tagrisso because Tagrisso blocks an enzyme that breaks down red yeast rice, potentially causing it to build up in your blood. This interaction may increase the risk of muscle pain and weakness similar to side effects seen with statin medications. It's important to tell your doctor about all supplements you're taking, including red yeast rice, and report any muscle symptoms that develop.

    Answered by Dr. Brian Staiger, PharmD · February 2023
  3. The pharmacist says

    The Premier Fermented Mushroom Blend contains only minimal amounts of green tea caffeine, which is unlikely to cause problems when taking Tagrisso. None of the other ingredients in this supplement are known to have clinically significant interactions with Tagrisso. Always inform your doctor about all supplements you're taking so they can monitor you appropriately, since there is often limited data on natural product interactions.

    Answered by Dr. Brian Staiger, PharmD · January 2023

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Yohimbe Also Interacts With Other Medications

Besides Osimertinib Mesylate, Yohimbe has 9 major, 679 moderate, 437 minor known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Yohimbe

Covers the 2,830 medications we’ve checked against Yohimbe. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Osimertinib Mesylate

Take other supplements too? 169 supplements have a documented interaction with Osimertinib Mesylate, each explained on its page.

By severity: 8 major, 120 moderate and 41 minor.

The Most Serious There Right Now:

Open the Osimertinib Mesylate interaction pageEvery supplement checked against Osimertinib Mesylate, ranked by severity
One More Smart Check

Taking Yohimbe as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Yohimbe. We have broken down 1,054 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Osimertinib Mesylate:

Get to Know Each One

About Yohimbe and Osimertinib Mesylate

Supplement

About Yohimbe

Yohimbe

Yohimbe is a West African tree bark that contains yohimbine, a compound mainly promoted for erectile dysfunction and as an aphrodisiac. A prescription form of yohimbine has some evidence for erectile dysfunction, but over-the-counter yohimbe supplements vary widely in content and can cause serious side effects like high blood pressure and fast heart rate. Because of these safety concerns, talk to your pharmacist or doctor before using it.

Full Yohimbe guide: uses, dosage, safety and every interaction
Medication

About Osimertinib

Brand name: Tagrisso

Osimertinib treats adults with non-small cell lung cancer (NSCLC) whose tumors have certain changes in the EGFR gene. An FDA-approved test is used to confirm the mutation.

Osimertinib: uses, dosage and side effects Osimertinib: interactions with other drugs Taking more than these two? Check Yohimbe and Osimertinib with everything else you take Osimertinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Yohimbe and Osimertinib Mesylate

Other drugs in the category this interaction applies to, and other supplements people check with Osimertinib Mesylate.

Moderate

Also in Our Cytochrome P450 3A4 (CYP3A4) Inhibitors Category

Yohimbe interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

146 more in this category are on the Yohimbe interactions list.

Minor

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Yohimbe interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

384 more in this category are on the Yohimbe interactions list.

Other Supplements With Osimertinib Mesylate

The most serious documented interactions with Osimertinib Mesylate first, then supplements with none on record, the most looked-up leading.

Show all 25 supplementsShow fewer
Keep Checking

Other Drugs & Yohimbe

Browse every other medication we’ve checked against Yohimbe — both the ones with a known interaction and the ones without. Select any drug for the full detail.

9Major
679Moderate
437Minor
1,704No known interaction
Major

Major: 9 interactions

Moderate

Moderate: 679 interactions

Showing 60 of 679 moderate interactions — see all 679 on the Yohimbe page.

Minor

Minor: 437 interactions

Showing 60 of 437 minor interactions — see all 437 on the Yohimbe page.

No Interaction 1,704 drugs checked — show the list
How Much People Look This Up

Where Yohimbe and Osimertinib Mesylate Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Yohimbe
Top 10%

#103 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Osimertinib Mesylate
Top half

#1,408 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Yohimbe and Osimertinib Mesylate Together: Common Questions

Can you take Yohimbe with Osimertinib Mesylate?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Yohimbe with Tagrisso?
Tagrisso is a brand name of osimertinib mesylate, so the answer is the same as for osimertinib mesylate. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Tagrisso too.
Why are there 2 interaction records for Yohimbe and Osimertinib Mesylate?
We file interactions under single medicines and under categories of medicines that share an effect. Osimertinib Mesylate is named in, or belongs to, 2 of the categories we list for Yohimbe, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Yohimbe and Osimertinib Mesylate interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Yohimbe and Osimertinib Mesylate?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.